Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.

Angle Plc

AGL
14,25
0,25 (1,79%)
19 Giu 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: Londra
Tipo: Azione Ordinaria
Valuta: GBX

Ultime notizie

Data Ora Fonte Titolo
18/6/202415:41LSEG_RNSAngle PLC Posting of 2023 Annual Report & Notice of the AGM
11/6/202408:00LSEG_NONAngle PLC Parsortix and assays being showcased at EACR 2024
06/6/202417:37LSEG_RNSAngle PLC Publication of Circular
05/6/202417:32ALNCNewsEARNINGS AND TRADING: STV sees advertising upturn; Angle..
05/6/202417:04LSEG_RNSAngle PLC Results of placing and subscription
05/6/202408:00LSEG_RNSAngle PLC Proposed Placing, Subscription and Open Offer
05/6/202408:00LSEG_RNSAngle PLC Preliminary Results
16/5/202421:09ALNCNewsTRADING UPDATES: Bens Creek considers administration; Nexxen..
16/5/202408:00LSEG_NONAngle PLC Study of ovarian cancer CTCs using Parsortix
03/5/202413:17ALNCNewsCORRECT: Angle shares up on assay development deal with..
03/5/202412:50ALNCNewsAngle shares up on assay development deal with AstraZenaca
03/5/202408:00LSEG_RNSAngle PLC New commercial agreement with large pharma
24/4/202411:32ALNCNewsAngle shares jump on supplier agreement with with..
24/4/202408:00LSEG_RNSAngle PLC New commercial agreement with AstraZeneca
22/4/202417:52ALNCNewsIN BRIEF: Angle granted patents in US and Europe for..
22/4/202408:00LSEG_RNSAngle PLC US and EU patents for innovative CellKeep™ slide
08/4/202408:00LSEG_NONAngle PLC Parsortix HER2 assay showcased at AACR 2024
22/3/202408:00LSEG_NONAngle PLC Parsortix at European breast cancer conference
22/1/202419:03ALNCNewsIN BRIEF: Angle highlights supportive data for DNA analysis..
22/1/202408:00RNSNONAngle PLC Potential utility in precision oncology
10/1/202413:57UKREGAngle PLC Standard form for notification of major holdings
04/1/202413:19ALNCNewsAngle shares soar following "breakthrough" cancer..
04/1/202410:10DJNAngle PLC Shares Rise on Cancer Patient Blood Sample..
04/1/202408:00UKREGAngle PLC Breakthrough clinical results
02/1/202409:51ALNCNewsIN BRIEF: Angle teams with Japan's Eisai in breast cancer..
02/1/202408:00UKREGAngle PLC Contract announcement with Eisai Inc.
11/12/202321:44ALNCNewsTRADING UPDATES: Ondine Biomedical raises GBP2.9 million via..
11/12/202308:00RNSNONAngle PLC Parsortix unlocks opportunities for drug discovery
11/12/202308:00UKREGAngle PLC Broker Announcement
05/12/202312:50ALNCNewsIN BRIEF: Angle launches diagnostic kit at cancer symposium
05/12/202308:00RNSNONAngle PLC ANGLE launches Portrait+ CTC kit at SABCS
09/11/202315:29ALNCNewsAngle says build up of revenue slower than hoped; launches..
09/11/202308:00UKREGAngle PLC Trading and business update
09/11/202308:00RNSNONAngle PLC Launch of PD-L1 test to support cancer studies
25/10/202318:28ALNCNewsTRADING UPDATES: Franchise Brands trading in line; Tribe..
25/10/202308:00RNSNONAngle PLC Supporting characterisation of CTCs in HNSCC
03/10/202314:02ALNCNewsAngle hails study which shows Parsortix outperforming lab..
03/10/202308:00RNSNONAngle PLC Parsortix outperforms standard for DTC harvest
29/9/202308:00RNSNONAngle PLC Parsortix system showcased at ACTC conference
07/9/202315:41ALNCNewsEARNINGS UPDATES: Sylvania beats production goal, Angle..
07/9/202308:00UKREGAngle PLC Interim Results for the period ended 30 June 2023
04/9/202315:21ALNCNewsAngle launches tumour cell assay to "unlock" customised..
04/9/202308:00RNSNONAngle PLC ANGLE launch of Portrait Flex assay
15/8/202308:00UKREGAngle PLC ANGLE notice of interim results
28/6/202317:54UKREGAngle PLC Result of 2023 Annual General Meeting
27/6/202313:24UKREGAngle PLC Standard form for notification of major holdings
Apertura: 14,00 Min: 14,00 Max: 14,75
Chiusura: 14,00

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network